Bioactive Oleic Acid Nanocarriers Boost Tobramycin Activity Against Resistant Bacteria and Biofilms

Read full text Summarise with VIRAT
Authors: Jules D. P. Valentin, Meron Debas, Yok‐Ai Que, Stefan Salentinig
Cited by: 0
References: 59

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antimicrobial resistance and biofilm formation increasingly limit the effectiveness of conventional antibiotics. Here, we report oleic acid (OA)-based lipid nanoparticles designed to enhance antibiotic activity within established biofilms. The nanoparticles are formed by co-assembling tobramycin (TOB) with OA, and kinetically stabilized with tocopheryl polyethylene glycol 1000 succinate (TPGS). Smallangle X-ray scattering, dynamic light scattering, and electrophoretic mobility analyses revealed negatively charged nanoparticles with an inverse micellar cubic internal structure. Increasing TOB loading beyond a TOB/OA ratio of 1/10 induced a transition to a lamellar organization while maintaining colloidal stability over several months. Encapsulation of TOB reduced the minimum bactericidal concentration against Pseudomonas aeruginosa by four-fold. In biofilm assays, nanoparticles containing 32 µg mL-1 TOB achieved a 6-log reduction in viable cells and prevented regrowth for at least 7 days, whereas 2048 µg mL-1 free TOB was required to suppress biofilm regrowth, corresponding to a 64-fold enhancement. Improved activity was also observed against multidrug-resistant Pseudomonas aeruginosa and Escherichia coli biofilms, while no improvement was detected for Staphylococcus aureus. These findings demonstrate that OA-based lipid nanoparticles can substantially enhance antibiotic efficacy without chemical modification of the drug, highlighting their potential as a platform for repurposing existing antibiotics against biofilm-associated and drug-resistant infections.

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Bacterial biofilms and quorum sensing Advanced Drug Delivery Systems

Publication details

Journal / source
ChemRxiv
Publication date
26 March 2026
Language
EN
Document type
Preprint